Tag: Pfizer
-
India to approve Oxford’s COVID-19 vaccine after UK’s nod
Oxford’s COVID-19 vaccine: After UK approved Oxford-AstraZeneca’s COVID-19 vaccine, India is likely to have its vaccine soon Britain’s approval of the Oxford-AstraZeneca COVID-19 vaccine for emergency use has given new hopes to India’s efforts to fight the rising cases in the country. As per media reports, Indian regulators are expected to hold further meetings in ... -
COVID-19: PM Modi reviews India’s vaccination strategy
India’s vaccination strategy: As the number of Coronavirus cases continues to surge across various states in India, Prime Minister Narendra Modi on Friday held a virtual meeting with top officials to review the vaccination strategy of the country and efforts needed to make the vaccine accessible to the public. Taking to Twitter, PM Modi stated ... -
Potential Covid-19 vaccines and the ideal candidate for India
Potential Covid-19 vaccines: As various countries, India too is hinging its hopes on the potential Covid-19 vaccines to be authorized by the regulatory bodies for their use, especially as its one of the leading nations with maximum Covid-19 positive cases. However, out of the many vaccines under different levels of trials globally, for India the ... -
India In Talks With Moderna Over 94.5% Vaccine Efficacy Proof
India In Talks With Moderna: The US biotech giant Moderna Therapeutics has confirmed that its Covid-19 vaccine sample guarantees a 94.5% success rate in its phase 3 efficacy trials. The Indian government is apparently in talks with the company over the development of the company’s vaccine candidate. According to a senior government official, “India is ... -
Trump pushes for a quick fix for Coronavirus amid fears of losing election
The novel coronavirus, Covid-19, has taken the world by storm, which hit medical, economic and political institutions across the globe. Till date the deadly virus has infected 109,900 persons in at least 97 countries and taken away more than 3800 lives, according to the data cited in the The New York Times. Who knew the ...